Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2298)
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
119,244
Price
$71.67
Total Value
$8.55M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
3,460
Price
$71.67
Total Value
$247.97K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
145,417
Price
$71.67
Total Value
$10.42M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
19,173
Price
$70.84
Total Value
$1.36M
Shares Held After
23,067
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
99,118
Price
$70.84
Total Value
$7.02M
Shares Held After
119,244
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,876
Price
$70.84
Total Value
$203.72K
Shares Held After
3,460
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
120,873
Price
$70.84
Total Value
$8.56M
Shares Held After
145,417
% of Holdings
45.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
11,223
% of Holdings
3.4%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
30,547
% of Holdings
1.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
114
Price
$14.98
Total Value
$1.71K
Shares Held After
169,556
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,979
Price
$14.60
Total Value
$101.89K
Shares Held After
169,670
% of Holdings
4.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
666
Price
$14.98
Total Value
$9.98K
Shares Held After
793,328
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
40,679
Price
$14.60
Total Value
$593.91K
Shares Held After
793,994
% of Holdings
4.9%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
37,167
Price
$70.00
Total Value
$2.60M
Shares Held After
8,383
% of Holdings
81.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
6,431
Price
$29.66
Total Value
$190.74K
Shares Held After
890,809
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,696
Price
$8.16
Total Value
$46.47K
Shares Held After
187,432
% of Holdings
2.9%
Burning Rock Biotech Ltd (BNR)
Han Yusheng — Director
Shares
5,990
Price
$7.50
Total Value
$44.92K
Shares Held After
18,129,186
% of Holdings
0.0%
Hongchang International Co., Ltd (HCIL)
Lin Zhenzhu — Director
Shares
1,450
Price
$0.12
Total Value
$174.00
Shares Held After
62,258,082
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
30,774
Price
$21.13
Total Value
$650.25K
Shares Held After
1,106,036
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
39,131
Price
$21.13
Total Value
$826.84K
Shares Held After
1,510,157
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
77,855
Price
$21.13
Total Value
$1.65M
Shares Held After
4,805,639
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
173
Price
$99.98
Total Value
$17.30K
Shares Held After
613,589
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,235
Price
$99.98
Total Value
$123.48K
Shares Held After
3,461,521
% of Holdings
0.0%
Trulieve Cannabis Corp. (TRLV)
Rivers Kim A. — Director
Shares
380,000
Price
$8.47
Total Value
$3.22M
Shares Held After
2,313,724
% of Holdings
14.1%
Aditxt, Inc. (ADTX)
Takeover Time 2026 LLC — 10% Owner
Shares
3,420,439
Price
$0.02
Total Value
$68.41K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
320
Price
$275.10
Total Value
$88.03K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,290
Price
$274.12
Total Value
$353.61K
Shares Held After
320
% of Holdings
80.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,800
Price
$273.30
Total Value
$491.95K
Shares Held After
1,610
% of Holdings
52.8%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
3,422
Price
$9.06
Total Value
$31.00K
Shares Held After
792,546
% of Holdings
0.4%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,068
Price
$276.74
Total Value
$295.55K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
117,592
Price
$54.47
Total Value
$6.41M
Shares Held After
559,399
% of Holdings
17.4%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
32,408
Price
$54.11
Total Value
$1.75M
Shares Held After
676,991
% of Holdings
4.6%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
9,900
Price
$9.04
Total Value
$89.50K
Shares Held After
865,559
% of Holdings
1.1%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,292
Price
$276.26
Total Value
$356.93K
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,450
Price
$18.00
Total Value
$26.10K
Shares Held After
51,776
% of Holdings
2.7%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
97
Price
$30.09
Total Value
$2.92K
Shares Held After
0
% of Holdings
100.0%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
31,912
Price
$29.58
Total Value
$943.96K
Shares Held After
97
% of Holdings
99.7%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
15,491
Price
$28.95
Total Value
$448.46K
Shares Held After
32,009
% of Holdings
32.6%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
102
Price
$30.09
Total Value
$3.07K
Shares Held After
0
% of Holdings
100.0%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
33,592
Price
$29.58
Total Value
$993.65K
Shares Held After
102
% of Holdings
99.7%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
16,306
Price
$28.95
Total Value
$472.06K
Shares Held After
33,694
% of Holdings
32.6%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
102
Price
$30.09
Total Value
$3.07K
Shares Held After
0
% of Holdings
100.0%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
33,591
Price
$29.58
Total Value
$993.62K
Shares Held After
102
% of Holdings
99.7%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
16,307
Price
$28.95
Total Value
$472.09K
Shares Held After
33,693
% of Holdings
32.6%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
1,799
Price
$30.09
Total Value
$54.13K
Shares Held After
480,866
% of Holdings
0.4%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
591,213
Price
$29.58
Total Value
$17.49M
Shares Held After
482,665
% of Holdings
55.1%
Oscar Health, Inc. (OSCR)
Schlosser Mario — Director
Shares
286,988
Price
$28.95
Total Value
$8.31M
Shares Held After
1,073,878
% of Holdings
21.1%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$117.94
Total Value
$1.06M
Shares Held After
7,825
% of Holdings
53.5%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
9,810
Price
$12.00
Total Value
$117.72K
Shares Held After
8,617
% of Holdings
53.2%
Showing 551–600 of 2298 transactions (page 12 of 46)